Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3374| Title: | Infant with end stage liver disease. Management of bleeding risk and use of blood products: Time for review | Authors: | Lewindon, P. Balouch, F. |
Issue Date: | 2016 | Source: | 52, (9), 2016, p. 901-904 | Pages: | 901-904 | Journal: | Journal of Paediatrics and Child Health | Abstract: | L6139614432017-01-09 | DOI: | 10.1111/jpc.13264 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L613961443&from=exporthttp://dx.doi.org/10.1111/jpc.13264 | | Keywords: | deep vein thrombosis;end stage liver disease;hemostasis;hepatosplenomegaly;human;infant;international normalized ratio;jaundice;laboratory test;liver failure;liver function;male;physical examination;priority journal;prothrombin time;case report;Australia;article;fresh frozen plasmavitamin K group;anticoagulation;child | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.